Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 27 3 2019
medline: 25 11 2020
entrez: 27 3 2019
Statut: ppublish

Résumé

GBM (glioblastoma multiforme) is the most common and aggressive brain tumor with no curative options available. Therefore, it is imperative to develop novel potent therapeutic drugs for GBM treatment. Here, we show that regorafenib, an oral multi-kinase inhibitor, exhibits superior therapeutic efficacy over temozolomide, the first-line chemotherapeutic agent for GBM treatment both

Identifiants

pubmed: 30909789
doi: 10.1080/15548627.2019.1598752
pmc: PMC6984601
doi:

Substances chimiques

Autophagy-Related Protein 5 0
MAP1LC3B protein, human 0
Microtubule-Associated Proteins 0
Phenylurea Compounds 0
Pyridines 0
SQSTM1 protein, human 0
Sequestosome-1 Protein 0
regorafenib 24T2A1DOYB
Transaminases EC 2.6.1.-
phosphoserine aminotransferase EC 2.6.1.52
TOR Serine-Threonine Kinases EC 2.7.11.1
AMP-Activated Protein Kinases EC 2.7.11.31

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

106-122

Références

Autophagy. 2014 Aug;10(8):1359-68
pubmed: 24991840
Cancer Cell. 2015 Oct 12;28(4):456-471
pubmed: 26412325
Cancer Discov. 2014 Oct;4(10):1120-2
pubmed: 25274683
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3041-6
pubmed: 22323597
Clin Cancer Res. 2014 Nov 15;20(22):5768-76
pubmed: 25248379
Cell Physiol Biochem. 2016;39(1):395-406
pubmed: 27372650
Autophagy. 2015;11(8):1408-24
pubmed: 26114578
Cell Death Differ. 2015 Mar;22(3):367-76
pubmed: 25257169
Autophagy. 2014 Jul;10(7):1241-55
pubmed: 24905460
Ann Intern Med. 2006 Mar 7;144(5):337-43
pubmed: 16520474
Sci Rep. 2017 May 18;7(1):2099
pubmed: 28522855
Cancer Cell. 2011 Dec 13;20(6):810-7
pubmed: 22137795
Cancer Lett. 2015 Mar 28;358(2):220-231
pubmed: 25542083
Mol Cell. 2018 Jan 4;69(1):87-99.e7
pubmed: 29249655
Int J Cancer. 2015 Feb 15;136(4):E39-50
pubmed: 25142862
EMBO J. 2015 Apr 1;34(7):856-80
pubmed: 25712477
J Exp Clin Cancer Res. 2016 Feb 02;35:23
pubmed: 26830677
Nat Rev Neurol. 2014 Jul;10(7):372-85
pubmed: 24912512
Mol Cancer. 2010 Jun 01;9:135
pubmed: 20515495
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
Autophagy. 2014 Aug;10(8):1391-402
pubmed: 24991838
Oncogene. 2015 Mar 19;34(12):1608
pubmed: 25790189
Acta Neuropathol. 2015 Jun;129(6):829-48
pubmed: 25943888
Cancer Lett. 2015 May 1;360(2):195-204
pubmed: 25681668
Lancet. 2013 Jan 26;381(9863):303-12
pubmed: 23177514
Br J Cancer. 2016 Mar 1;114(5):485-96
pubmed: 26889975
Cell Metab. 2016 Sep 13;24(3):494-501
pubmed: 27476977
Cell. 2009 Jun 12;137(6):1001-4
pubmed: 19524504
Mol Cancer. 2008 Jan 25;7:14
pubmed: 18221502
Autophagy. 2016;12(1):1-222
pubmed: 26799652
Mol Med Rep. 2015 Sep;12(3):3681-3687
pubmed: 26017247
Science. 2017 Nov 10;358(6364):807-813
pubmed: 29074583
Neuro Oncol. 2010 May;12(5):473-81
pubmed: 20406898
Cell. 2005 Sep 23;122(6):927-39
pubmed: 16179260
Biomed Pharmacother. 2018 Jan;97:844-850
pubmed: 29136760
Neurosurg Focus. 2014 Dec;37(6):E12
pubmed: 25434381
Int J Oncol. 2007 Feb;30(2):429-36
pubmed: 17203225
Lancet. 2017 Jan 7;389(10064):56-66
pubmed: 27932229
Nat Rev Cancer. 2017 Sep;17(9):528-542
pubmed: 28751651
Nat Cell Biol. 2011 Sep 02;13(9):1016-23
pubmed: 21892142
Cell. 2014 Mar 27;157(1):65-75
pubmed: 24679527
PLoS One. 2013;8(1):e55096
pubmed: 23383069
Nat Rev Cancer. 2016 Oct;16(10):650-62
pubmed: 27634448
Lancet. 2013 Jan 26;381(9863):295-302
pubmed: 23177515
Proc Natl Acad Sci U S A. 2013 Dec 17;110(51):20364-71
pubmed: 24277826
Cancer Med. 2017 Oct;6(10):2331-2346
pubmed: 28857517
Nat Rev Drug Discov. 2017 Jul;16(7):487-511
pubmed: 28529316
Nat Rev Clin Oncol. 2013 Jan;10(1):14-26
pubmed: 23183634
Cell Rep. 2015 Dec 22;13(11):2610-2620
pubmed: 26686643
Annu Rev Biochem. 2017 Jun 20;86:305-331
pubmed: 28375741
J Clin Invest. 2017 Feb 1;127(2):415-426
pubmed: 28145904
Autophagy. 2011 Sep;7(9):966-78
pubmed: 21610320
Cancer Res. 2016 Aug 1;76(15):4457-69
pubmed: 27302166
Nat Rev Cancer. 2016 Oct;16(10):619-34
pubmed: 27492215
Clin Cancer Res. 2014 Jul 1;20(13):3472-84
pubmed: 24763611
Neurosurg Focus. 2003 Feb 15;14(2):e3
pubmed: 15727424
Curr Opin Genet Dev. 2011 Feb;21(1):113-9
pubmed: 21255998
Nat Cell Biol. 2015 Nov;17(11):1484-96
pubmed: 26479318
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
EMBO J. 2016 Jan 18;35(2):121-42
pubmed: 26702100

Auteurs

Jingwen Jiang (J)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Lu Zhang (L)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Haining Chen (H)

Department of Gastrointestinal Surgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Yunlong Lei (Y)

Department of Biochemistry and Molecular Biology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, P.R. China.

Tao Zhang (T)

The School of Biomedical Sciences, Chengdu Medical College, Chengdu, P.R. China.

Yuelong Wang (Y)

Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Ping Jin (P)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Jiang Lan (J)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Li Zhou (L)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Zhao Huang (Z)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Bowen Li (B)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Yuan Liu (Y)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Wei Gao (W)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Ke Xie (K)

Department of Oncology, Sichuan Provincial People's Hospital, Chengdu, P.R. China.

Liangxue Zhou (L)

Department of Neurosurgery, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Edouard C Nice (EC)

Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.

Yong Peng (Y)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Yihai Cao (Y)

Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

Yuquan Wei (Y)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Kui Wang (K)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Canhua Huang (C)

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, and West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, P.R. China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH